<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK425723" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK425723/" /><meta name="ncbi_pagename" content="Myhre Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Myhre Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Myhre Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/04/13" /><meta name="citation_author" content="Lois J Starr" /><meta name="citation_author" content="Noralane M Lindor" /><meta name="citation_author" content="Angela E Lin" /><meta name="citation_pmid" content="28406602" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK425723/" /><meta name="citation_keywords" content="Laryngotracheal Stenosis, Arthropathy, Prognathism, and Short Stature (LAPS) Syndrome" /><meta name="citation_keywords" content="Myhre-LAPS Syndrome" /><meta name="citation_keywords" content="Laryngotracheal Stenosis, Arthropathy, Prognathism, and Short Stature (LAPS) Syndrome" /><meta name="citation_keywords" content="Myhre-LAPS Syndrome" /><meta name="citation_keywords" content="Mothers against decapentaplegic homolog 4" /><meta name="citation_keywords" content="SMAD4" /><meta name="citation_keywords" content="Myhre Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Myhre Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lois J Starr" /><meta name="DC.Contributor" content="Noralane M Lindor" /><meta name="DC.Contributor" content="Angela E Lin" /><meta name="DC.Date" content="2017/04/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK425723/" /><meta name="description" content="Myhre syndrome is a connective tissue disorder with multisystem involvement, progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, mild-to-moderate intellectual disability, and in some instances, autistic-like behaviors. Organ systems primarily involved include: cardiovascular (congenital heart defects, long- and short-segment stenosis of the aorta and peripheral arteries, pericardial effusion, constrictive pericarditis, restrictive cardiomyopathy, and hypertension); respiratory (choanal stenosis, laryngotracheal narrowing, obstructive airway disease, or restrictive pulmonary disease), gastrointestinal (pyloric stenosis, duodenal strictures, severe constipation); and skin (thickened particularly on the hands and extensor surfaces). Additional findings include distinctive craniofacial features and skeletal involvement (intrauterine growth restriction, short stature, limited joint range of motion). To date, 55 individuals with molecularly confirmed Myhre syndrome have been reported." /><meta name="og:title" content="Myhre Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Myhre syndrome is a connective tissue disorder with multisystem involvement, progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, mild-to-moderate intellectual disability, and in some instances, autistic-like behaviors. Organ systems primarily involved include: cardiovascular (congenital heart defects, long- and short-segment stenosis of the aorta and peripheral arteries, pericardial effusion, constrictive pericarditis, restrictive cardiomyopathy, and hypertension); respiratory (choanal stenosis, laryngotracheal narrowing, obstructive airway disease, or restrictive pulmonary disease), gastrointestinal (pyloric stenosis, duodenal strictures, severe constipation); and skin (thickened particularly on the hands and extensor surfaces). Additional findings include distinctive craniofacial features and skeletal involvement (intrauterine growth restriction, short stature, limited joint range of motion). To date, 55 individuals with molecularly confirmed Myhre syndrome have been reported." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK425723/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/myhre/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK425723/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D661DE0403F810000000006760240.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK425723_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK425723_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/m-sulfatase-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mfm/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK425723_"><span class="title" itemprop="name">Myhre Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Laryngotracheal Stenosis, Arthropathy, Prognathism, and Short Stature (LAPS) Syndrome; Myhre-LAPS Syndrome</div><p class="contrib-group"><span itemprop="author">Lois J Starr</span>, MD, <span itemprop="author">Noralane M Lindor</span>, MD, and <span itemprop="author">Angela E Lin</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK425723_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK425723_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lois J Starr</span>, MD<div class="affiliation small">University of Nebraska Medical Center<br />Omaha, Nebraska<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmnu@rratsl" class="oemail">ude.cmnu@rratsl</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Noralane M Lindor</span>, MD<div class="affiliation small">Mayo Clinic<br />Phoenix, Arizona<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@rodniln" class="oemail">ude.oyam@rodniln</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Angela E Lin</span>, MD<div class="affiliation small">MassGeneral Hospital for Children<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hgm@alegna.nil" class="oemail">ude.dravrah.hgm@alegna.nil</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 13, 2017</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="myhre.Summary" itemprop="description"><h2 id="_myhre_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Myhre syndrome is a connective tissue disorder with multisystem involvement, progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, mild-to-moderate intellectual disability, and in some instances, autistic-like behaviors. Organ systems primarily involved include: cardiovascular (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, long- and short-segment stenosis of the aorta and peripheral arteries, pericardial effusion, constrictive pericarditis, restrictive cardiomyopathy, and hypertension); respiratory (choanal stenosis, laryngotracheal narrowing, obstructive airway disease, or restrictive pulmonary disease), gastrointestinal (pyloric stenosis, duodenal strictures, severe constipation); and skin (thickened particularly on the hands and extensor surfaces). Additional findings include distinctive craniofacial features and skeletal involvement (intrauterine growth restriction, short stature, limited joint range of motion). To date, 55 individuals with molecularly confirmed Myhre syndrome have been reported.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Myhre syndrome is established by detecting a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical findings.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Symptomatic treatment (with attention to limiting tissue trauma by minimizing instrumentation during diagnosis and management) by specialty experts of the following involvement: cardiovascular, respiratory (including tracheostomy when tracheal stenosis is recurrent or complete), and GI; routine management of speech and language delay, intellectual disability, behavioral problems.</p><p><i>Prevention of secondary complications:</i> Limiting of tissue trauma given the apparent increased risk for proliferative fibrosis following otherwise uncomplicated endotracheal intubation and surgical procedures. When possible, alternative noninvasive approaches should be pursued during diagnosis and management</p><p><i>Surveillance:</i> Cardiovascular: echocardiogram every one to three years in asymptomatic individuals with a normal echocardiogram at the time of initial diagnosis; in individuals with abnormal cardiac findings at the time of diagnosis, more extensive imaging (including possible cardiac MRI) may be considered. Respiratory: oxygen saturation in children with monitoring as needed for symptoms suggestive of restrictive/obstructive pulmonary disease; annual pulmonary function studies in children oldert than age six years if able to cooperate; evaluation of laryngotracheal stenosis based on symptoms. Annual ophthalmology and audiology evaluations.</p><p><i>Agents/circumstances to avoid:</i> Smoking; tissue trauma.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Myhre syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. All probands with Myhre syndrome reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If the <i>SMAD4</i> pathogenic variant found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. To date, individuals with Myhre syndrome are not known to reproduce and fertility has not been assessed. Once the <i>SMAD4</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at theoretic increased risk for Myhre syndrome and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="myhre.Diagnosis"><h2 id="_myhre_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria have not been published for Myhre syndrome.</p><div id="myhre.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Myhre syndrome <b>should be suspected</b> in individuals with the following clinical and radiographic findings.</p><div id="myhre.Clinical"><h4>Clinical</h4><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>Arterial obstruction: juxtaductal coarctation of the aorta, long- and short-segment descending thoracic and abdominal aortic obstruction, and peripheral arteries in various locations; infrequently, branch pulmonary artery stenosis</div></li><li class="half_rhythm"><div>Congenital heart defects:</div><ul><li class="half_rhythm"><div>Atrial and ventricular septal defects, patent ductus arteriosus</div></li><li class="half_rhythm"><div>Valvular stenosis: aortic and mitral valves; infrequently, tricuspid and pulmonic valves</div></li></ul></li><li class="half_rhythm"><div>Pericardial involvement: ranges from effusion to constrictive pericarditis; often chronic and severe</div></li><li class="half_rhythm"><div>Restrictive cardiomyopathy (can be rapidly progressive)</div></li><li class="half_rhythm"><div>Hypertension: systemic and pulmonary</div></li></ul><p><b>Respiratory (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or acquired)</b></p><ul><li class="half_rhythm"><div>Laryngotracheal narrowing (including subglottic stenosis)</div></li><li class="half_rhythm"><div>Choanal stenosis</div></li><li class="half_rhythm"><div>Obstructive airway disease</div></li><li class="half_rhythm"><div>Restrictive pulmonary disease (which appears to increase with age)</div></li></ul><p><b>Gastrointestinal</b></p><ul><li class="half_rhythm"><div>Congenital or acquired pyloric stenosis</div></li><li class="half_rhythm"><div>Later onset:</div><ul><li class="half_rhythm"><div>Duodenal strictures</div></li><li class="half_rhythm"><div>Severe constipation</div></li></ul></li></ul><p><b>Skin</b></p><ul><li class="half_rhythm"><div>Stiff and thickened overall, but particularly on the hands and extensor surfaces</div></li><li class="half_rhythm"><div>Facial creases fewer than expected for age</div></li></ul><p><b>Proliferative fibrosis/scarring</b></p><ul><li class="half_rhythm"><div>May occur spontaneously or following trauma or surgery</div></li><li class="half_rhythm"><div>May involve the serosal surfaces of the heart, airway and lungs, and gastrointestinal tract as well as the skin</div></li></ul><p><b>Neuropsychiatric</b></p><ul><li class="half_rhythm"><div>Mild-to-moderate intellectual disability</div></li><li class="half_rhythm"><div>Autistic-like behaviors in some</div></li></ul><p><b>Craniofacial</b></p><ul><li class="half_rhythm"><div>Characteristic facial features including short palpebral fissures, deeply set eyes, maxillary underdevelopment, short philtrum, narrow mouth, thin vermilion of the upper lip, and prognathism (<a class="figpopup" href="/books/NBK425723/figure/myhre.F1/?report=objectonly" target="object" rid-figpopup="figmyhreF1" rid-ob="figobmyhreF1">Figure 1</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F2/?report=objectonly" target="object" rid-figpopup="figmyhreF2" rid-ob="figobmyhreF2">Figure 2</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-figpopup="figmyhreF3" rid-ob="figobmyhreF3">Figure 3</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F4/?report=objectonly" target="object" rid-figpopup="figmyhreF4" rid-ob="figobmyhreF4">Figure 4</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" rid-figpopup="figmyhreF5" rid-ob="figobmyhreF5">Figure 5</a>). Facial characteristics can progress over time; although classic coarsening of features is not present, mandibular elongation is notable. Note: Craniofacial features can vary considerably.</div></li><li class="half_rhythm"><div>Cleft lip and/or palate and velopharyngeal insufficiency reported in 13% [<a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al 2016</a>]</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF1" co-legend-rid="figlgndmyhreF1"><a href="/books/NBK425723/figure/myhre.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF1" rid-ob="figobmyhreF1"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image001.gif" src-large="/books/NBK425723/bin/myhre-Image001.jpg" alt="Figure 1. . Female with Myhre syndrome at ages seven months, four years, and 16 years." /></a><div class="icnblk_cntnt" id="figlgndmyhreF1"><h4 id="myhre.F1"><a href="/books/NBK425723/figure/myhre.F1/?report=objectonly" target="object" rid-ob="figobmyhreF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Female with Myhre syndrome at ages seven months, four years, and 16 years. Note the short palpebral fissures, thin upper vermilion border and maxillary underdevelopment. She required tracheostomy subsequent to traumatic intubations that resulted in complete <a href="/books/NBK425723/figure/myhre.F1/?report=objectonly" target="object" rid-ob="figobmyhreF1">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF2" co-legend-rid="figlgndmyhreF2"><a href="/books/NBK425723/figure/myhre.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF2" rid-ob="figobmyhreF2"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image002.gif" src-large="/books/NBK425723/bin/myhre-Image002.jpg" alt="Figure 2. . Female with Myhre syndrome at ages newborn, 12 months, 3." /></a><div class="icnblk_cntnt" id="figlgndmyhreF2"><h4 id="myhre.F2"><a href="/books/NBK425723/figure/myhre.F2/?report=objectonly" target="object" rid-ob="figobmyhreF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Female with Myhre syndrome at ages newborn, 12 months, 3.5 years, and seven years. Note the short palpebral fissures, thin upper vermilion border, and progression of mild prognathism. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF3" co-legend-rid="figlgndmyhreF3"><a href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF3" rid-ob="figobmyhreF3"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image003.gif" src-large="/books/NBK425723/bin/myhre-Image003.jpg" alt="Figure 3. . Female with Myhre syndrome at ages three years, ten years (standing), and 21 years (face, posterior hairline, and hands)." /></a><div class="icnblk_cntnt" id="figlgndmyhreF3"><h4 id="myhre.F3"><a href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-ob="figobmyhreF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Female with Myhre syndrome at ages three years, ten years (standing), and 21 years (face, posterior hairline, and hands). Note the short palpebral fissures, broad mid-upper nasal bridge, downward pointing nasal tip, thin upper vermilion border, broad <a href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-ob="figobmyhreF3">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF4" co-legend-rid="figlgndmyhreF4"><a href="/books/NBK425723/figure/myhre.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF4" rid-ob="figobmyhreF4"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image004.gif" src-large="/books/NBK425723/bin/myhre-Image004.jpg" alt="Figure 4. . Male with Myhre syndrome at age 12 years." /></a><div class="icnblk_cntnt" id="figlgndmyhreF4"><h4 id="myhre.F4"><a href="/books/NBK425723/figure/myhre.F4/?report=objectonly" target="object" rid-ob="figobmyhreF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Male with Myhre syndrome at age 12 years. Note the mild facial features (mild maxillary underdevelopment and thin upper vermilion border) and finger contractures (hands are on a flat surface). </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF5" co-legend-rid="figlgndmyhreF5"><a href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" title="Figure 5. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF5" rid-ob="figobmyhreF5"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image005.gif" src-large="/books/NBK425723/bin/myhre-Image005.jpg" alt="Figure 5. . Female with Myhre syndrome at age five years." /></a><div class="icnblk_cntnt" id="figlgndmyhreF5"><h4 id="myhre.F5"><a href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" rid-ob="figobmyhreF5">Figure 5. </a></h4><p class="float-caption no_bottom_margin">Female with Myhre syndrome at age five years. Note the short palpebral fissures, thin upper and lower vermilion borders, left-sided facial palsy, and brachydactyly with otherwise mild features. Facial palsy is observed in 4% of individuals with Myhre <a href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" rid-ob="figobmyhreF5">(more...)</a></p></div></div><p><b>Skeletal</b></p><ul><li class="half_rhythm"><div>Infants typically have intrauterine growth restriction (IUGR)</div></li><li class="half_rhythm"><div>Short stature (height is significantly less than that predicted by parental heights) with compact body habitus</div></li><li class="half_rhythm"><div>Range of motion of the joints can be limited</div></li></ul></div><div id="myhre.Radiographic"><h4>Radiographic</h4><p>Findings include the following:</p><ul><li class="half_rhythm"><div>Thickened calvarium</div></li><li class="half_rhythm"><div>Shortened long bones</div></li><li class="half_rhythm"><div>Brachydactyly</div></li><li class="half_rhythm"><div>Broad ribs</div></li><li class="half_rhythm"><div>Enlarged vertebrae with shortened pedicles; vertebral fusion</div></li><li class="half_rhythm"><div>Hypoplastic iliac wings</div></li></ul><p>See <a class="figpopup" href="/books/NBK425723/figure/myhre.F6/?report=objectonly" target="object" rid-figpopup="figmyhreF6" rid-ob="figobmyhreF6">Figure 6</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmyhreF6" co-legend-rid="figlgndmyhreF6"><a href="/books/NBK425723/figure/myhre.F6/?report=objectonly" target="object" title="Figure 6. " class="img_link icnblk_img figpopup" rid-figpopup="figmyhreF6" rid-ob="figobmyhreF6"><img class="small-thumb" src="/books/NBK425723/bin/myhre-Image006.gif" src-large="/books/NBK425723/bin/myhre-Image006.jpg" alt="Figure 6. " /></a><div class="icnblk_cntnt" id="figlgndmyhreF6"><h4 id="myhre.F6"><a href="/books/NBK425723/figure/myhre.F6/?report=objectonly" target="object" rid-ob="figobmyhreF6">Figure 6. </a></h4><p class="float-caption no_bottom_margin">Radiographs of a female age 14 years A. Thickened calvaria and anterior cervical vertebral fusion (arrow) of C2 and C3.</p></div></div></div></div><div id="myhre.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Myhre syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical findings and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD4</i> detected by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK425723/table/myhre.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figmyhreTmoleculargenetictestingusedi" rid-ob="figobmyhreTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may not. Persons with the distinctive findings described in <a href="#myhre.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#myhre.Option_1">Option 1</a>), whereas those in whom a specific diagnosis has been elusive are more likely to be diagnosed using genomic testing (see <a href="#myhre.Option_2">Option 2</a>).</p><div id="myhre.Option_1"><h4>Option 1</h4><p>When the phenotypic and radiographic findings suggest the diagnosis of Myhre syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SMAD4</i> is performed first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> may be considered; to date, however, no <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions have been reported.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SMAD4</i> and other genes of interest (see <a href="#myhre.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="myhre.Option_2"><h4>Option 2</h4><p>When the diagnosis of Myhre syndrome has not been considered, <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>), when available, is likely to be the diagnostic modality selected. Comprehensive genome sequencing includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and genome sequencing.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="myhre.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Myhre Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425723/table/myhre.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myhre.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD4</i></td><td headers="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">55/55&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_myhre.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="myhre.TF.1.1"><p class="no_margin">See <a href="/books/NBK425723/#myhre.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="myhre.TF.1.2"><p class="no_margin">See <a href="#myhre.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="myhre.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="myhre.TF.1.4"><p class="no_margin">54 patients summarized by <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a> and one patient reported by <a class="bk_pop" href="#myhre.REF.bassett.2016.54">Bassett et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="myhre.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="myhre.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="myhre.Clinical_Characteristics"><h2 id="_myhre_Clinical_Characteristics_">Clinical Characteristics</h2><div id="myhre.Clinical_Description"><h3>Clinical Description</h3><p>Myhre syndrome is a multisystem connective tissue disorder involving: the cardiovascular system, respiratory system, gastrointestinal tract, and skin; progressive and proliferative fibrosis that may occur spontaneously or following trauma or surgery, often resulting in significant complications; mild-to-moderate intellectual disability; and behavioral issues in some. Additional findings include distinctive craniofacial features and skeletal involvement.</p><p>Myhre syndrome was first described by <a class="bk_pop" href="#myhre.REF.myhre.1981.1">Myhre et al [1981]</a> in two unrelated males. Since 2011, when heterozygosity for a <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was found to be causative, 55 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a molecularly confirmed diagnosis of Myhre syndrome have been reported. <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a> reported four affected individuals and summarized findings in 50 previously reported individuals [<a class="bk_pop" href="#myhre.REF.le_goff.2011.85">Le Goff et al 2011</a>, <a class="bk_pop" href="#myhre.REF.al_ageeli.2012.541">Al Ageeli et al 2012</a>, <a class="bk_pop" href="#myhre.REF.asakura.2012.1982">Asakura et al 2012</a>, <a class="bk_pop" href="#myhre.REF.caputo.2012.161">Caputo et al 2012</a>, <a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>, <a class="bk_pop" href="#myhre.REF.picco.2013.1164">Picco et al 2013</a>, <a class="bk_pop" href="#myhre.REF.ishibashi.2014.300">Ishibashi et al 2014</a>, <a class="bk_pop" href="#myhre.REF.kenis.2014.e253">Kenis et al 2014</a>, <a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.hawkes.2015.84">Hawkes &#x00026; Kini 2015</a>, <a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>]. Subsequently <a class="bk_pop" href="#myhre.REF.bassett.2016.54">Bassett et al [2016]</a> reported one additional affected individual.</p><p>Note: Unless otherwise noted, the following findings are reported in <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a>.</p><p><b>Infancy and progression of findings.</b> In infancy, characteristic facial features are usually present, but more difficult to recognize than in an older child (see <a href="#myhre.Suggestive_Findings">Suggestive Findings</a> and <a class="figpopup" href="/books/NBK425723/figure/myhre.F1/?report=objectonly" target="object" rid-figpopup="figmyhreF1" rid-ob="figobmyhreF1">Figure 1</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F2/?report=objectonly" target="object" rid-figpopup="figmyhreF2" rid-ob="figobmyhreF2">Figure 2</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-figpopup="figmyhreF3" rid-ob="figobmyhreF3">Figure 3</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F4/?report=objectonly" target="object" rid-figpopup="figmyhreF4" rid-ob="figobmyhreF4">Figure 4</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" rid-figpopup="figmyhreF5" rid-ob="figobmyhreF5">Figure 5</a>). Short stature and hearing loss develop over time as well as the highly distinctive (and often severe) findings of Myhre syndrome: joint stiffness, restrictive lung and cardiovascular disease, progressive and proliferative fibrosis, and thickening of the skin.</p><p><b>Cardiovascular.</b> Of 54 individuals with a confirmed molecular diagnosis of Myhre syndrome, 70% had a cardiovascular abnormality including structural heart defects (63%); pericardial disease (17%), restrictive cardiomyopathy (9%), and systemic hypertension (15%).</p><p>Cardiovascular abnormalities include the following:</p><ul><li class="half_rhythm"><div>Atrial septal defect (4%) and ventricular septal defect (6%)</div></li><li class="half_rhythm"><div>Patent ductus arteriosus (which can be large) (20%)</div></li><li class="half_rhythm"><div>Obstructive defects of the left heart, such as juxtaductal aortic coarctation (15%), long-segment aorta narrowing (6%), aortic valve stenosis (15%), and mitral valve stenosis (2%). These are more common than obstructive defects of the right-side, such as valvar and branch pulmonary artery stenosis [<a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.hawkes.2015.84">Hawkes &#x00026; Kini 2015</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</div></li><li class="half_rhythm"><div>Peripheral vascular stenoses (in celiac and/or renal arteries) (7%)</div></li></ul><p>Of note, complex <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects are not observed.</p><p>Pericardial disease (reported in 17%) can present as a short-term or recurrent effusion or as chronic or progressive constrictive pericarditis that may require surgical intervention (see <a href="#myhre.Management">Management</a>).</p><p>Restrictive cardiomyopathy, a lethal condition, is the least common form of cardiomyopathy in the general population and can be overlooked unless cardiac catheterization documents the characteristic hemodynamics.</p><p>While constrictive pericarditis and restrictive cardiomyopathy can present with similar hemodynamics, they differ in pathogenesis and treatment (see <a href="#myhre.Management">Management</a>).</p><p>Pulmonary hypertension has been infrequently reported; however, this may reflect limited evaluation and/or bias toward ascertainment and/or reporting of younger patients (as underlying causes of pulmonary hypertension resulting from involvement of the lungs and cardiovascular circulation may evolve with age).</p><p>Progressive cardiovascular issues can appear at any age; those with onset in childhood may worsen following instrumentation: two patients with restrictive cardiomyopathy who were treated with heart and heart/lung transplantation did not survive postoperative complications [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</p><p><b>Respiratory.</b> Respiratory issues can be <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a>. Airway stenosis, typically involving the larynx and trachea, has included subglottic stenosis (17%) that can be recurrent and severe. Less common is upper airway obstruction due to choanal stenosis (11%).</p><p>Restrictive and obstructive pulmonary disease are major causes of morbidity at all ages. Interstitial lung disease has been described. Severe pulmonary fibrosis has been noted on autopsy [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</p><p><b>Gastrointestinal involvement</b></p><ul><li class="half_rhythm"><div>Duodenal atresia 3/54 (6%)</div></li><li class="half_rhythm"><div>Late-onset pyloric stenosis [L Starr, personal observation]</div></li><li class="half_rhythm"><div>Protein-losing enteropathy (Patient 1 [<a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al 2016</a>])</div></li><li class="half_rhythm"><div>Severe constipation [<a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>]</div></li></ul><p><b>Cutaneous.</b> Generalized thickening/stiffness of the skin is seen in nearly all individuals with Myhre syndrome. Various terms used to describe the skin include thick, stiff, firm, rough, keratotic, and inelastic. Additional findings are minimal creasing of the facial skin and fibrous and keloid-like scar formation.</p><p>Skin changes may not be apparent in infancy; they are often first noted on extensor surfaces, palms, and soles. The changes progress with age.</p><p><b>Neuropsychiatric.</b> Data are limited. Mild-to-moderate intellectual disability and developmental delay are common; however, cognition can be within the normal range. Of note, acquired and unrecognized hearing loss may also contribute to speech delay and academic and social challenges.</p><p>Findings of autism spectrum disorder have been noted in a minority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>].</p><p><b>Skeletal.</b> The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants have intrauterine growth restriction (41/49; 84%). Short stature with compact body habitus (with normal head circumference) becomes more apparent over time. Adult height is expected to be more than two standard deviations below what is predicted by parental heights.</p><p>Small hands and feet with brachydactyly is usually notable (see <a class="figpopup" href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-figpopup="figmyhreF3" rid-ob="figobmyhreF3">Figure 3</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F4/?report=objectonly" target="object" rid-figpopup="figmyhreF4" rid-ob="figobmyhreF4">Figure 4</a>, <a class="figpopup" href="/books/NBK425723/figure/myhre.F5/?report=objectonly" target="object" rid-figpopup="figmyhreF5" rid-ob="figobmyhreF5">Figure 5</a>).</p><p>Posture may be distinct with flexed elbows and bending forward at the hips (see <a class="figpopup" href="/books/NBK425723/figure/myhre.F3/?report=objectonly" target="object" rid-figpopup="figmyhreF3" rid-ob="figobmyhreF3">Figure 3</a> and <a class="bk_pop" href="#myhre.REF.ishibashi.2014.300">Ishibashi et al [2014]</a>, Figure 1).</p><p>Reduced range of motion of large and small joints is characteristic and is exacerbated with age. Walking on tiptoes is common.</p><p><b>Immune system.</b> Recurrent infections (especially otitis media and pneumonia) have been reported in 19 of 34 individuals. Increased susceptibility to infection has been associated with immunoglobulin deficiency in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals; IVIG was utilized with reported benefit in one affected individual [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>]. At this point, it is unknown if immune deficiency is associated with Myhre syndrome or if it is an incidental finding [<a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</p><p><b>Ophthalmologic.</b> At least one abnormal eye finding was reported in 53% (26/49) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals:</p><ul><li class="half_rhythm"><div>Strabismus 13/53 (24%)</div></li><li class="half_rhythm"><div>Refractive errors in 17/53 (31%)</div></li><li class="half_rhythm"><div>Other. Cataracts, astigmatism, and optic nerve sheath meningioma</div></li></ul><p><b>Hearing loss</b> is observed in most (83%) individuals with Myhre syndrome.</p><p>Hearing loss is predominantly conductive, but can be sensorineural and mixed. The underlying etiology of the hearing loss is often unclear or unknown; most often patients have a history of bilateral myringotomy tube placement.</p><p>Of note, most infants pass their newborn hearing screen. In the authors' experience hearing loss usually becomes evident in early childhood and is typically present in adults.</p><p><b>Endocrine.</b> Puberty has been reported to be normal, premature, or delayed. Secondary amenorrhea has been reported.</p><p><b>Neoplasia</b></p><ul><li class="half_rhythm"><div>Endometrial carcinoma [<a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>], optic nerve sheath meningioma [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>], and mesencephalic glioma [<a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al 2016</a>] have each been reported once.</div></li><li class="half_rhythm"><div>Telangiectasias and juvenile polyps, reported in heterozygotes for a <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, have not been reported in Myhre syndrome; however, information to date is limited.</div></li></ul></div><div id="myhre.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <i>SMAD4</i> pathogenic variants that cause Myhre syndrome involve only two protein residues (codons 496 and 500). To date, no clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are evident in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with either codon abnormality.</p><p>Of note, although the three individuals reported with the p.Arg496C variant do not have cardiovascular involvement and are taller in stature &#x02013; two on the growth curve (2<sup>nd</sup>-25<sup>th</sup> centile) and one &#x0003c;1<sup>st</sup> centile [<a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.caputo.2014.1835">Caputo et al 2014</a>] &#x02013; the data are too limited to draw any conclusions about <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p></div><div id="myhre.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete; however, no <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases of Myhre syndrome have been reported.</p></div><div id="myhre.Nomenclature"><h3>Nomenclature</h3><p>LAPS (<i>l</i>aryngotracheal stenosis, <i>a</i>rthropathy, <i>p</i>rognathism, and <i>s</i>hort stature) syndrome was determined to be a phenotypic variant of Myhre syndrome with pathogenic variants in the same codons [<a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>, <a class="bk_pop" href="#myhre.REF.picco.2013.1164">Picco et al 2013</a>, <a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>]; the term is no longer in use.</p></div><div id="myhre.Prevalence"><h3>Prevalence</h3><p>The prevalence is unknown.</p><p>Since 2011 when a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD4</i> was discovered to be the cause of Myhre syndrome, 55 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a molecularly confirmed diagnosis have been reported worldwide with no apparent ethnic or sex predilection (54 summarized in <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a> and one reported by <a class="bk_pop" href="#myhre.REF.bassett.2016.54">Bassett et al [2016]</a>).</p></div></div><div id="myhre.Genetically_Related_Allelic_Disord"><h2 id="_myhre_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>SMAD4</i>:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/jps/">Juvenile polyposis syndrome</a> (JPS)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hht/">Hereditary hemorrhagic telangiectasia</a> (HHT)</div></li></ul><p>Whereas Myhre syndrome is caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <i>SMAD4</i> pathogenic variants (see <a href="#myhre.Molecular_Genetics">Molecular Genetics</a>), JPS and HHT are caused by heterozygous <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>SMAD4</i> pathogenic variants.</p></div><div id="myhre.Differential_Diagnosis"><h2 id="_myhre_Differential_Diagnosis_">Differential Diagnosis</h2><p>The disorders that most closely resemble Myhre syndrome are the other acromelic dysplasias: geleophysic dysplasia, acromicric dysplasia, and Weill-Marchesani syndrome, which share the findings of thickened skin, short stature, short hands, and stiff joints. MULIBREY nanism should also be considered.</p><div id="myhre.T.disorders_to_consider_in_the_dif" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Myhre Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425723/table/myhre.T.disorders_to_consider_in_the_dif/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myhre.T.disorders_to_consider_in_the_dif_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential<br />Diagnosis<br />Disorder</th><th id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4" id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Myhre syndrome</th><th headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4" id="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Myhre syndrome</th></tr></thead><tbody><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acromicric dysplasia<br />(OMIM <a href="http://omim.org/entry/102370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">102370</a>)</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Brachydactyly</div></li><li class="half_rhythm"><div>Joint stiffness</div></li><li class="half_rhythm"><div>Thickened skin</div></li></ul>
</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Characteristic external notch of 5th metacarpal &#x00026; internal notch of femoral head</div></li><li class="half_rhythm"><div>Absence of hearing loss</div></li><li class="half_rhythm"><div>Less frequent cardiac anomalies</div></li><li class="half_rhythm"><div>Absence of calvarial thickening</div></li></ul>
</td></tr><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/geleophys-dysp/">Geleophysic dysplasia</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAMTSL2</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Short hands &#x00026; feet</div></li><li class="half_rhythm"><div>Progressive joint limitation &#x00026; contractures</div></li><li class="half_rhythm"><div>Progressive cardiac valvar thickening</div></li><li class="half_rhythm"><div>Thickened skin</div></li></ul>
</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Characteristic facies</div></li></ul>
</td></tr><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/weill-ms/">Weill-Marchesani syndrome</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAMTS10</i><br /><i>LTPBP2</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Brachydactyly</div></li><li class="half_rhythm"><div>Joint stiffness</div></li></ul>
</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Distinctive lens abnormalities&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Lack of hearing loss</div></li></ul>
</td></tr><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MULIBREY nanism<br />(OMIM <a href="http://omim.org/entry/253250" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">253250</a>)</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRIM37</i></td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Relatively large head</div></li><li class="half_rhythm"><div>Constrictive pericarditis</div></li><li class="half_rhythm"><div>Restrictive cardiomyopathy</div></li></ul>
</td><td headers="hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_myhre.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Shorter stature</div></li><li class="half_rhythm"><div>Small tongue</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; IUGR = intrauterine growth restriction; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="myhre.TF.2.1"><p class="no_margin"><b>Geleophysic dysplasia.</b> Major findings are likely to be present in the first year of life. Cardiac and respiratory involvement result in death before age five years in approximately 33% of individuals with geleophysic dysplasia 1.</p></div></dd><dt>2. </dt><dd><div id="myhre.TF.2.2"><p class="no_margin"><b>Weill-Marchesani syndrome.</b> The ocular problems, typically recognized in childhood, include microspherophakia (small spherical lens), myopia secondary to the abnormal shape of the lens, ectopia lentis (abnormal position of the lens), and glaucoma, which can lead to blindness.</p></div></dd></dl></div></div></div></div><div id="myhre.Management"><h2 id="_myhre_Management_">Management</h2><div id="myhre.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Myhre syndrome, the following are recommended (if not completed previously as part of the diagnostic evaluation).</p><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>Upper- and lower-extremity blood pressure measurements</div></li><li class="half_rhythm"><div>Two-dimensional echocardiography with Doppler</div></li><li class="half_rhythm"><div>For those with abnormal findings, more extensive imaging if indicated including cardiac catheterization to document the characteristic hemodynamics of restrictive cardiomyopathy</div></li></ul><p><b>Respiratory</b></p><ul><li class="half_rhythm"><div>Assessment for airway stenosis by the least invasive means possible with assessment for signs of upper-airway obstruction including noisy breathing, work of breathing, and oxygen saturation</div></li><li class="half_rhythm"><div>Assessment of pulmonary function and oxygen saturation for evidence of obstructive or restrictive lung disease</div></li></ul><p><b>Gastrointestinal.</b> Based on clinical indication (by least invasive means possible), evaluate for evidence of stenosis.</p><p><b>Neuropsychiatric.</b> Neuropsychometric evaluation may be indicated for individuals with autistic behaviors and/or cognitive involvement.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Ophthalmology evaluation</div></li><li class="half_rhythm"><div>Speech evaluation</div></li><li class="half_rhythm"><div>Audiology evaluation</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="myhre.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is largely symptomatic and may include the following.</p><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>Management by a cardiologist trained in <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, including pericardial disease and restrictive cardiomyopathy. At present, no evidence suggests that in Myhre syndrome management of specific lesions would differ from standard care in current clinical practice, except that any unnecessary instrumentation should be avoided as associated tissue trauma may induce stenosis and the scarring-type tissue response unique to Myhre syndrome.</div></li><li class="half_rhythm"><div>Affected individuals who are in heart failure should be under the care of a cardiovascular specialist with access to a transplant center.</div></li><li class="half_rhythm"><div>Maximize all medical treatment and minimize instrumentation for all cardiac studies and therapies.</div></li><li class="half_rhythm"><div>Medical treatment of systemic hypertension and pulmonary hypertension (based on underlying cause).</div></li></ul><p><b>Respiratory</b></p><ul><li class="half_rhythm"><div>Affected individuals have required long-term tracheostomy due to complete and recurrent tracheal stenosis following multiple and/or traumatic intubations [<a class="bk_pop" href="#myhre.REF.mcgowan.2011.e553">McGowan et al 2011</a>, <a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>]. To avoid traumatic intubation, consider using a size-smaller uncuffed endotracheal tube. Elective tracheal surgery/intubation should be avoided; tracheal resection is contraindicated [<a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>].</div></li><li class="half_rhythm"><div>Symptomatic treatment of restrictive lung disease</div></li><li class="half_rhythm"><div>Oxygen supplementation as necessary</div></li></ul><p><b>Gastrointestinal</b></p><ul><li class="half_rhythm"><div>Minimal instrumentation of the gastrointestinal tract is advised because post-operative adhesions can be fatal [<a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>].</div></li><li class="half_rhythm"><div>Endoscopy should be approached with caution to avoid airway manipulation which increases the risk for tracheal/laryngeal scarring/stenosis [<a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>]. Noninvasive 3D imaging may be preferred.</div></li><li class="half_rhythm"><div>Aggressive management of constipation (through dietary means or medication if necessary) is indicated.</div></li></ul><div id="myhre.Developmental_Delay__Intellectual"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years.</b> In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</p><p>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="myhre.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p><p>Individualized behavioral therapy or pharmacologic treatment for anxiety, depression, or other psychological manifestations as per current clinical practice is appropriate.</p></div><div id="myhre.Other_Issues"><h4>Other Issues</h4><p><b>Hearing</b></p><ul><li class="half_rhythm"><div><b>Hearing loss.</b> Appropriate hearing augmentation (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>)</div></li><li class="half_rhythm"><div><b>Persistent middle ear effusions.</b> Myringotomy tubes as needed</div></li></ul><p><b>Craniofacial</b></p><ul><li class="half_rhythm"><div>Individuals with orofacial clefting or velopharyngeal insufficiency should be referred to a craniofacial clinic with pediatric experience. These individuals benefit most from a multidisciplinary approach to care.</div></li><li class="half_rhythm"><div>A craniofacial clinic associated with a major pediatric medical center usually includes a surgical team (craniofacial surgeon and neurosurgeon), clinical geneticist, ophthalmologist, otolaryngologist, pediatrician, radiologist, psychologist, multiple dental specialists, audiologist, speech therapist, and social worker.</div></li></ul><p><b>Skeletal</b></p><ul><li class="half_rhythm"><div>Consider physical therapy to keep joints mobile (no study has been done on efficacy). Note: It is not known if passive range of motion exercises help maintain flexibility.</div></li><li class="half_rhythm"><div>A systematic study of growth hormone treatment for short stature has not been done. One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been noted to have anecdotal improvement in growth velocity; however, it is unknown if adult height would be affected [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</div></li></ul><p><b>Ophthalmology.</b> Routine treatment of strabismus and refractive errors. Note: Complications from surgical repair have not been reported.</p></div></div><div id="myhre.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Limiting tissue trauma appears to be the single most important preventive measure: The literature suggests increased risk of proliferative fibrosis following otherwise uncomplicated endotracheal intubation and surgical procedures. When possible, alternative noninvasive approaches should be pursued during diagnosis and management [<a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>].</p><ul><li class="half_rhythm"><div>Extreme care with intubation and use of an endotracheal tube without a cuff (or careful monitoring of pressures with a cuff) may help prevent airway stenosis [<a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>].</div></li><li class="half_rhythm"><div>Minimize abdominal and pelvic procedures as extensive adhesions may develop postoperatively [<a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>].</div></li><li class="half_rhythm"><div>Hysterectomy should be an option of last resort for treatment of menorrhagia as post-surgical fibrosis is highly likely.</div></li></ul></div><div id="myhre.Surveillance"><h3>Surveillance</h3><p><b>Cardiovascular</b></p><ul><li class="half_rhythm"><div>After normal baseline evaluations of upper- and lower-extremity blood pressure measurements, two-dimensional echocardiography with Doppler, and cardiology evaluation</div></li><li class="half_rhythm"><div>In asymptomatic individuals with a normal echocardiogram at the time of <a href="#myhre.Evaluations_Following_Initial_Diag">initial diagnosis</a>, repeat echocardiogram every 1-3 years. Note that pericardial effusion and restrictive cardiomyopathy may occur at any age and may be clinically asymptomatic [<a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>, <a class="bk_pop" href="#myhre.REF.garavelli.2016.1307">Garavelli et al 2016</a>, <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al 2016</a>].</div></li><li class="half_rhythm"><div>In individuals with abnormal findings at the time of <a href="#myhre.Evaluations_Following_Initial_Diag">initial diagnosis</a>, more extensive imaging may be indicated given the progressive nature of the disorder (e.g., MRI to evaluate for pericardial thickening or effusion).</div></li></ul><p><b>Respiratory</b></p><ul><li class="half_rhythm"><div>Consider oxygen saturation in children, with monitoring as needed for symptoms suggestive of restrictive/obstructive pulmonary disease and annual pulmonary function studies in children older than age six years if able to cooperate with test maneuvers.</div></li><li class="half_rhythm"><div>Evaluation for upper airway stenosis (e.g., laryngotracheal stenosis) should be considered based on symptoms.</div></li></ul><p><b>Other</b></p><ul><li class="half_rhythm"><div>Annual ophthalmologic and audiology evaluations</div></li><li class="half_rhythm"><div>Monitoring of physical skill development and joint mobility</div></li></ul></div><div id="myhre.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Patients should be aggressively counseled not to smoke.</p><p>Limiting tissue trauma appears to be the single most important preventive concept in this disorder to communicate to all health care providers involved in their care (see <a href="#myhre.Prevention_of_Secondary_Complicati">Prevention of Secondary Findings</a>).</p></div><div id="myhre.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#myhre.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="myhre.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="myhre.Genetic_Counseling"><h2 id="_myhre_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="myhre.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Myhre syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="myhre.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>All probands with Myhre syndrome reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see <a class="bk_pop" href="#myhre.REF.bassett.2016.54">Bassett et al [2016]</a>; <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a> and references therein).</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> If the <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> To date, individuals with Myhre syndrome are not known to reproduce and fertility has not been assessed.</p><p><b>Other family members.</b> The risk to other family members is presumed to be low given that all probands with Myhre syndrome reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (i.e., no <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases of Myhre syndrome have been reported).</p></div><div id="myhre.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="myhre.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at theoretic increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Myhre syndrome are possible.</p></div></div><div id="myhre.Resources"><h2 id="_myhre_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/myhre-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myhre syndrome</a></div></li><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="myhre.Molecular_Genetics"><h2 id="_myhre_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="myhre.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Myhre Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425723/table/myhre.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myhre.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_myhre.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_myhre.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_myhre.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_myhre.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_myhre.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_myhre.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_myhre.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4089" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SMAD4</i></a></td><td headers="hd_b_myhre.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4089" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">18q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_myhre.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13485" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mothers against decapentaplegic homolog 4</a></td><td headers="hd_b_myhre.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://arup.utah.edu/database/SMAD4/SMAD4_display.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD4 Database</a><br /><a href="http://databases.lovd.nl/shared/genes/SMAD4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD4 database</a></td><td headers="hd_b_myhre.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SMAD4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD4</a></td><td headers="hd_b_myhre.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SMAD4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD4</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="myhre.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="myhre.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Myhre Syndrome (<a href="/omim/139210,600993" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425723/table/myhre.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myhre.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/139210" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">139210</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MYHRE SYNDROME; MYHRS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600993" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600993</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4</td></tr></tbody></table></div></div><div id="myhre.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Myhre syndrome is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that confers stability on the abnormal SMAD4 protein due to an apparent decrease in monoubiquitination. This disrupts TGF&#x003b2; signaling, thus altering expression of downstream target genes encoding TGF&#x003b2; and bone morphogenic proteins (BMP), resulting in abnormal development of the axial and appendicular skeleton, cardiac muscle, and central nervous system [<a class="bk_pop" href="#myhre.REF.caputo.2012.161">Caputo et al 2012</a>, <a class="bk_pop" href="#myhre.REF.le_goff.2014.503">Le Goff et al 2014</a>].</p><p>In contrast, heterozygosity for a <b>loss</b>-of-function <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been well established as the cause of a spectrum of acquired cardiac diseases, including cardiac fibrosis and hypertrophy, aortopathies, atherogenesis, and pulmonary artery hypertension.</p><p><b>Gene structure.</b> The coding exons 2-12 of <i>SMAD4</i> constitute a 552-residue protein composed of two domains. Exon 1 is noncoding.</p><p><b>Pathogenic variants.</b> The four pathogenic variants reported to date are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that are restricted to residues 496 and 500 (<a class="figpopup" href="/books/NBK425723/table/myhre.T.smad4_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figmyhreTsmad4pathogenicvariantsdiscus" rid-ob="figobmyhreTsmad4pathogenicvariantsdiscus">Table 3</a>). No <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> deletions or duplications have been reported in individuals with Myhre syndrome.</p><p>Since 2011, when heterozygosity for a <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was found to be causative, 55 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a molecularly confirmed diagnosis of Myhre syndrome have been reported. <a class="bk_pop" href="#myhre.REF.lin.2016.2617">Lin et al [2016]</a> reported four affected individuals and summarized findings in 50 previously reported individuals [<a class="bk_pop" href="#myhre.REF.le_goff.2011.85">Le Goff et al 2011</a>, <a class="bk_pop" href="#myhre.REF.al_ageeli.2012.541">Al Ageeli et al 2012</a>, <a class="bk_pop" href="#myhre.REF.asakura.2012.1982">Asakura et al 2012</a>, <a class="bk_pop" href="#myhre.REF.caputo.2012.161">Caputo et al 2012</a>, <a class="bk_pop" href="#myhre.REF.lindor.2012.1520">Lindor et al 2012</a>, <a class="bk_pop" href="#myhre.REF.picco.2013.1164">Picco et al 2013</a>, <a class="bk_pop" href="#myhre.REF.ishibashi.2014.300">Ishibashi et al 2014</a>, <a class="bk_pop" href="#myhre.REF.kenis.2014.e253">Kenis et al 2014</a>, <a class="bk_pop" href="#myhre.REF.michot.2014.1272">Michot et al 2014</a>, <a class="bk_pop" href="#myhre.REF.hawkes.2015.84">Hawkes &#x00026; Kini 2015</a>, <a class="bk_pop" href="#myhre.REF.oldenburg.2015.636">Oldenburg et al 2015</a>, <a class="bk_pop" href="#myhre.REF.starr.2015.2893">Starr et al 2015</a>]. Subsequently <a class="bk_pop" href="#myhre.REF.bassett.2016.54">Bassett et al [2016]</a> reported one additional affected individual.</p><div id="myhre.T.smad4_pathogenic_variants_discus" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>SMAD4</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK425723/table/myhre.T.smad4_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__myhre.T.smad4_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1486C&#x0003e;T</td><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg496Cys</td><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_005359.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005359<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/NP_005350.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005350<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1498A&#x0003e;G</td><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile500Val</td></tr><tr><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1499T&#x0003e;C</td><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile500Thr</td></tr><tr><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1500A&#x0003e;G</td><td headers="hd_h_myhre.T.smad4_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile500Met</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The three functional classes of SMADs are:</p><ul><li class="half_rhythm"><div><i>SMAD4</i> that encodes a SMAD protein known as the co-mediator of the SMADs;</div></li><li class="half_rhythm"><div>SMAD1, SMAD2, SMAD3, SMAD5, and SMAD8 that are the receptor-regulated SMADs (or R-SMADs);</div></li><li class="half_rhythm"><div>SMAD6 and SMAD7 that are inhibitory SMADs.</div></li></ul><p>SMAD4 (mothers against decapentaplegic homolog 4) forms heterodimers with the receptor-regulated SMADs, which are translocated to the nucleus of the cell, which then (via an unclear mechanism) regulates the expression of TGB&#x003b2; and BMP pathway genes.</p><p>The 11 coding exons of <i>SMAD4</i> constitute a 552-residue protein composed of two domains [<a class="bk_pop" href="#myhre.REF.shi.2003.685">Shi &#x00026; Massague 2003</a>, <a class="bk_pop" href="#myhre.REF.le_goff.2011.85">Le Goff et al 2011</a>, <a class="bk_pop" href="#myhre.REF.caputo.2012.161">Caputo et al 2012</a>]:</p><ul><li class="half_rhythm"><div>Mad homology 1 (MH1), which contributes to DNA binding</div></li><li class="half_rhythm"><div>Mad homology 2 (MH2), which activates transcription</div></li></ul><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Codons 496 and 500 are in the Mad homology 2 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>; pathogenic variants in these codons confer a gain of function to the protein. The work of <a class="bk_pop" href="#myhre.REF.le_goff.2011.85">Le Goff et al [2011]</a> indicated that defective transcriptional regulation during development plays a significant role in the disorder.</p><p><b>Cancer and benign tumors.</b> Although <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> (<a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a>) pathogenic variants predispose to hamartomatous polyps in the gastrointestinal track (see <a href="/books/n/gene/jps/">Juvenile Polyposis Syndrome</a>), the <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> pathogenic variants associated with Myhre syndrome show no such associations (see <a href="#myhre.Clinical_Description">Clinical Description</a>, <b>Neoplasia</b>).</p><p>Note that somatic inactivation of <i>SMAD4,</i> a gastrointestinal malignancy-specific tumor suppressor <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, is found in one third of colorectal cancer specimens and half of pancreatic tumors. See <a class="bk_pop" href="#myhre.REF.chen.2014.181">Chen et al [2014]</a> and references therein.</p></div></div><div id="myhre.References"><h2 id="_myhre_References_">References</h2><div id="myhre.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.al_ageeli.2012.541">Al Ageeli E, Mignot C, Afenjar A, Whalen S, Dorison N, Mayer M, Esteva B, Dubern B, Momtchilova M, Le Gargasson JF, Bursztyn J, Heron D. Retinal involvement in two unrelated patients with Myhre syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:541–7.</span> [<a href="/pubmed/22683461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22683461</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.asakura.2012.1982">Asakura Y, Muroya K, Sato T, Kurosawa K, Nishimaura G, Adachi M. First case of a Japanese girl with Myhre syndrome due to a heterozygous SMAD4 mutation. <span><span class="ref-journal">Am J Med Genet Part A. </span>2012;<span class="ref-vol">158A</span>:1982–6.</span> [<a href="/pubmed/22711472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22711472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.bassett.2016.54">Bassett JK, Douzgou S, Kerr B. Severe constipation in a patient with Myhre syndrome: a case report. <span><span class="ref-journal">Clin Dysmorph. </span>2016;<span class="ref-vol">25</span>:54–7.</span> [<a href="/pubmed/26636501" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26636501</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.caputo.2014.1835">Caputo V, Bocchinfuso G, Castori M, Traversa A, Pizzuti A, Stella L, Grammatico P, Tartaglia M. Novel SMAD4 mutation causing Myhre syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2014;<span class="ref-vol">164A</span>:1835–40.</span> [<a href="/pubmed/24715504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24715504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.caputo.2012.161">Caputo V, Cianetti L, Niceta M, Carta C, Ciolfi A, Bocchinfuso G, Carrani E, Dentici ML, Biamino E, Belligni E, Garavelli L, Boccone L, Melis D, Andria G, Gelb BD, Stella L, Silengo M, Dallapiccola B, Tartaglia M. A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:161–9.</span> [<a href="/pmc/articles/PMC3257749/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257749</span></a>] [<a href="/pubmed/22243968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22243968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.chen.2014.181">Chen YW, Hsiao PJ, Weng CC, Kuo KK, Kuo TL, Wu DC, Hung WC, Cheng KH. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. <span><span class="ref-journal">BMC Cancer. </span>2014;<span class="ref-vol">14</span>:181.</span> [<a href="/pmc/articles/PMC4007528/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4007528</span></a>] [<a href="/pubmed/24625091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24625091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.garavelli.2016.1307">Garavelli L, Maini I, Baccilieri F, Ivanovski I, Pollazzon M, Rosato S, Iughetti L, Unger S, Superti-Furga A, Tartaglia M. Natural history and life-threatening complications in Myhre syndrome and review of the literature. <span><span class="ref-journal">Eur J Pediatr. </span>2016;<span class="ref-vol">175</span>:1307–15.</span> [<a href="/pubmed/27562837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27562837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.hawkes.2015.84">Hawkes L, Kini U. Myhre syndrome with facial paralysis and branch pulmonary stenosis. <span><span class="ref-journal">Clin Dysmorph. </span>2015;<span class="ref-vol">24</span>:84–5.</span> [<a href="/pubmed/25486016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25486016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.ishibashi.2014.300">Ishibashi N, Sasaki Y, Asakura Y. Myhre syndrome: a rare craniofacial disorder. <span><span class="ref-journal">Cranio. </span>2014;<span class="ref-vol">32</span>:300–6.</span> [<a href="/pubmed/25252769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25252769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.kenis.2014.e253">Kenis C, Verstreken M, Gieraerts K, De Foer B, Van der Aa N, Offeciers EF, Casselman JW. Bilateral otospongiosis and a unilateral vestibular schwannoma in a patient with Myhre syndrome. <span><span class="ref-journal">Otol Neurotol. </span>2014;<span class="ref-vol">35</span>:e253–5.</span> [<a href="/pubmed/24841914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24841914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.le_goff.2014.503">Le Goff C, Michot C, Cormier-Daire V. Myhre syndrome. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">85</span>:503–13.</span> [<a href="/pubmed/24580733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24580733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.le_goff.2011.85">Le Goff C, Mahaut C, Abhyankar A, Le Goff W, Serre V, Afenjar A, Destr&#x000e9;e A, di Rocco M, H&#x000e9;ron D, Jacquemont S, Marlin S, Simon M, Tolmie J, Veroles A, Casanova JL, Munnich A, Cormier-Daire V. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">44</span>:85–8.</span> [<a href="/pubmed/22158539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22158539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.lin.2016.2617">Lin AE, Michot C, Cormier-Daire V, L'Ecuyer TJ, Matherne GP, Barnes BH, Humberson JB, Edmondson AC, Zackai E, O'Connor MJ, Kaplan JD, Ebeid MR, Krier J, Krieg E, Ghoshhajra B, Lindsay ME. Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:2617–31.</span> [<a href="/pubmed/27302097" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27302097</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.lindor.2012.1520">Lindor NM, Gunawardena SR, Thibodeau SN. Mutations of SMAD4 account for both LAPS and Myhre syndromes. <span><span class="ref-journal">Am J Med Genet Part A. </span>2012;<span class="ref-vol">158A</span>:1520–1.</span> [<a href="/pubmed/22585601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22585601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.mcgowan.2011.e553">McGowan R, Gulati R, McHenry P, Cooke A, Butler S, Teik Keng W, Murday V, Whiteford M, Dikkers FG, Sikkema-Raddatz B, van Essen T, Tolmie J. Clinical features and respiratory complications in Myhre syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2011;<span class="ref-vol">54</span>:e553–e559.</span> [<a href="/pubmed/21816239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21816239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.michot.2014.1272">Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks AS, Campeau PM, Destree A, Di Rocco M, Donnai D, Hennekam R, Heron D, Jacquemont S, Kannu P, Lin AE, Manouvrier-Hanu S, Mansour S, Marlin S, McGowan R, Murphy H, Raas-Rothchild A, Rio M, Simon M, Stolte-Dijkstra I, Stone JR, Szanjer Y, Tolmie J, Touraine R, Ende JVD, Van der Aa N, Essen TV, Verloes A, Munnich A, Comier-Daire V. Myhre and LAPS syndromes: clinical and molecular review of 32 patients. <span><span class="ref-journal">Eur J Hum Genet. </span>2014;<span class="ref-vol">22</span>:1272–7.</span> [<a href="/pmc/articles/PMC4200423/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4200423</span></a>] [<a href="/pubmed/24424121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24424121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.myhre.1981.1">Myhre SA, Ruvalcaba RH, Graham CB. A new growth deficiency syndrome. <span><span class="ref-journal">Clin Genet. </span>1981;<span class="ref-vol">20</span>:1–5.</span> [<a href="/pubmed/7296942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7296942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.oldenburg.2015.636">Oldenburg MS, Frisch CD, Lindor NM, Edell ES, Kasperbauer JL, O'Brien EK. Myhre-LAPs syndrome and intubation related airway stenosis: keys to diagnosis and critical therapeutic interventions. <span><span class="ref-journal">Am J Otolaryngol. </span>2015;<span class="ref-vol">36</span>:636–41.</span> [<a href="/pubmed/25940662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25940662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.picco.2013.1164">Picco P, Naselli A, Pala G, Marsciani A, Buoncompagni A, Martini A. Recurrent pericarditis in Myhre syndrome. <span><span class="ref-journal">Am J Med Genet Part A. </span>2013;<span class="ref-vol">161A</span>:1164–6.</span> [<a href="/pubmed/23610053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23610053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.shi.2003.685">Shi Y, Massague J. Mechanisms of TGF-&#x003b2; signaling from cell membrane to the nucleus. <span><span class="ref-journal">Cell. </span>2003;<span class="ref-vol">113</span>:685–700.</span> [<a href="/pubmed/12809600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12809600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="myhre.REF.starr.2015.2893">Starr LJ, Grange DK, Delaney JW, Yetman AT, Hammel JM, Sanmann JN, Perry DA, Schaefer GB, Olney AH. Myhre syndrome: Clinical features and restrictive cardiopulmonary complications. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2893–901.</span> [<a href="/pubmed/26420300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26420300</span></a>]</div></li></ul></div></div><div id="myhre.Chapter_Notes"><h2 id="_myhre_Chapter_Notes_">Chapter Notes</h2><div id="myhre.Acknowledgments"><h3>Acknowledgments</h3><p>The authors are indebted to the people living with Myhre syndrome and their families who have provided consent, motivation, contributions, and advocacy.</p></div><div id="myhre.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 April 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>11 July 2016 (ljs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK425723</span><span class="label">PMID: <a href="/pubmed/28406602" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28406602</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/m-sulfatase-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mfm/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK425723&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK425723/?report=reader">PubReader</a></li><li><a href="/books/NBK425723/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK425723" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK425723" style="display:none" title="Cite this Page"><div class="bk_tt">Starr LJ, Lindor NM, Lin AE. Myhre Syndrome. 2017 Apr 13. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK425723/pdf/Bookshelf_NBK425723.pdf">PDF version of this page</a> (1.3M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#myhre.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#myhre.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#myhre.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#myhre.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#myhre.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#myhre.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#myhre.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#myhre.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#myhre.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#myhre.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#myhre.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4089[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SMAD4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4395580" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4395580" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4395580" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4395580" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25940662" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Myhre-LAPs syndrome and intubation related airway stenosis: keys to diagnosis and critical therapeutic interventions.</a><span class="source">[Am J Otolaryngol. 2015]</span><div class="brieflinkpop offscreen_noflow">Myhre-LAPs syndrome and intubation related airway stenosis: keys to diagnosis and critical therapeutic interventions.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Oldenburg MS, Frisch CD, Lindor NM, Edell ES, Kasperbauer JL, O'Brien EK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Otolaryngol. 2015 Sep-Oct; 36(5):636-41. Epub 2015 Apr 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24424121" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Myhre and LAPS syndromes: clinical and molecular review of 32 patients.</a><span class="source">[Eur J Hum Genet. 2014]</span><div class="brieflinkpop offscreen_noflow">Myhre and LAPS syndromes: clinical and molecular review of 32 patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks AS, Campeau PM, Destree A, Di Rocco M, Donnai D, Hennekam R, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2014 Nov; 22(11):1272-7. Epub 2014 Jan 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301680" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Costello Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gripp KW, Rauen KA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27302097" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome.</a><span class="source">[Am J Med Genet A. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin AE, Michot C, Cormier-Daire V, L'Ecuyer TJ, Matherne GP, Barnes BH, Humberson JB, Edmondson AC, Zackai E, O'Connor MJ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2016 Oct; 170(10):2617-31. Epub 2016 Jun 14.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28406602" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28406602" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04135ddde0891169bd813d">Myhre Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Myhre Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:56:45-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D661DE0403F810000000006760240&amp;ncbi_session=CE8D661DE04135C1_1654SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK425723%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK425723&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK425723/&amp;ncbi_pagename=Myhre Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D661DE04135C1_1654SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>